Abstract: Methods are provided herein for selectively killing senescent cells and for treating senescence-associated diseases and disorders by administering a senolytic agent. Senescence-associated diseases and disorders treatable by the methods using the senolytic agents described herein include cardiovascular diseases and disorders associated with or caused by arteriosclerosis, such as atherosclerosis; idiopathic pulmonary fibrosis; chronic obstructive pulmonary disease; osteoarthritis; senescence-associated ophthalmic diseases and disorders; and senescence-associated dermatological diseases and disorders.

Abstract: A deployable marker banner structure and system including (a) an elongate, rollable/unrollable fabric body having opposite ends, a long axis, and opposite faces, (b) shape-forming biasing structure operatively connected to the body, applying shape-forming biasing forces thereto at plural, spaced locations distributed along the body's long axis in a manner whereby, with the body unrolled, the biasing structure produces complex, alternating, longitudinally distributed convex and concave topography portions in the body's faces, with at least one each of such convex and concave topography portions disposed in each face of the body, and with each convex topography portion in one face of the body corresponding, and being complementary, to a companion concave topography portion located directly in the opposite face of the body, and (c) facial visibility-enhancing structure operatively present at least on the convex topography portions in the body's faces, urged by the mentioned topography portions into complex conve

Abstract: A deployable marker banner structure and system including (a) an elongate, rollable/unrollable fabric body having opposite ends, a long axis, and opposite faces, (b) shape-forming biasing structure operatively connected to the body, applying shape-forming biasing forces thereto at plural, spaced locations distributed along the body's long axis in a manner whereby, with the body unrolled, the biasing structure produces complex, alternating, longitudinally distributed convex and concave topography portions in the body's faces, with at least one each of such convex and concave topography portions disposed in each face of the body, and with each convex topography portion in one face of the body corresponding, and being complementary, to a companion concave topography portion located directly in the opposite face of the body, and (c) facial visibility-enhancing structure operatively present at least on the convex topography portions in the body's faces, urged by the mentioned topography portions into complex conve